Ting‐Tsung Chang

10.7k total citations · 4 hit papers
113 papers, 7.7k citations indexed

About

Ting‐Tsung Chang is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Ting‐Tsung Chang has authored 113 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Hepatology, 92 papers in Epidemiology and 17 papers in Infectious Diseases. Recurrent topics in Ting‐Tsung Chang's work include Hepatitis B Virus Studies (79 papers), Hepatitis C virus research (76 papers) and Liver Disease Diagnosis and Treatment (62 papers). Ting‐Tsung Chang is often cited by papers focused on Hepatitis B Virus Studies (79 papers), Hepatitis C virus research (76 papers) and Liver Disease Diagnosis and Treatment (62 papers). Ting‐Tsung Chang collaborates with scholars based in Taiwan, United States and China. Ting‐Tsung Chang's co-authors include Rong‐Nan Chien, Ching‐Lung Lai, Richard Guan, Seng Gee Lim, Nancy W.Y. Leung, Patrick Marcellin, Dar‐In Tai, Stephanos J. Hadziyannis, G. Kitis and Carol Brosgart and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

Ting‐Tsung Chang

112 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A One-Year Trial of Lamivudine for Chronic Hepatitis B

1998 1.4k citations Ching‐Lung Lai, Rong‐Nan Chien et al. profile →
Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B

2003 749 citations Ting‐Tsung Chang, Patrick Marcellin et al. profile →
Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years

2006 703 citations Ting‐Tsung Chang, Patrick Marcellin et al. Gastroenterology profile →
Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B

2000 575 citations Yun‐Fan Liaw, Nancy W.Y. Leung et al. Gastroenterology profile →

Peers

Ting‐Tsung Chang

EPIDE

HEPAT

SURGE

Marc Bourlière France

Etsuro Orito Japan

Chia‐Ming Chu Taiwan

Ola Weiland Sweden

Yves Benhamou France

Kenneth Koury United States

Teerha Piratvisuth Thailand

Rong‐Nan Chien Taiwan

Stephanos J. Hadziyannis Greece

Alessandra Mangia Italy

Marc Bourlière France

Ting‐Tsung Chang

7.0k ×1.0

EPIDE

7.6k ×1.1

HEPAT

1.3k ×1.0

323 ×1.1

462 ×1.9

SURGE

Citations per year, relative to Ting‐Tsung Chang Ting‐Tsung Chang (= 1×) peers Marc Bourlière

Countries citing papers authored by Ting‐Tsung Chang

Since Specialization

Citations

This map shows the geographic impact of Ting‐Tsung Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting‐Tsung Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting‐Tsung Chang more than expected).

Fields of papers citing papers by Ting‐Tsung Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ting‐Tsung Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting‐Tsung Chang. The network helps show where Ting‐Tsung Chang may publish in the future.

Co-authorship network of co-authors of Ting‐Tsung Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Ting‐Tsung Chang. A scholar is included among the top collaborators of Ting‐Tsung Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting‐Tsung Chang. Ting‐Tsung Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kao, Jia‐Horng, Rong‐Nan Chien, Ting‐Tsung Chang, et al.. (2016). A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection. Liver International. 36(8). 1101–1107. 22 indexed citations

Chuang, Wan‐Long, Rong‐Nan Chien, Cheng‐Yuan Peng, et al.. (2016). Ledipasvir/sofosbuvir fixed‐dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus. Journal of Gastroenterology and Hepatology. 31(7). 1323–1329. 22 indexed citations

Manns, Michael P., Ulus Salih Akarca, Ting‐Tsung Chang, et al.. (2012). Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901. Expert Opinion on Drug Safety. 11(3). 361–368. 38 indexed citations

Wu, I‐Chin, Ching‐Lung Lai, Steven-Huy Han, et al.. (2009). Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy‐proven histological damage†. Hepatology. 51(4). 1185–1189. 37 indexed citations

Lu, Sheng‐Nan, Wei‐Wen Su, Sheng‐Shun Yang, et al.. (2006). Secular trends and geographic variations of hepatitis B virus and hepatitis C virus‐associated hepatocellular carcinoma in Taiwan. International Journal of Cancer. 119(8). 1946–1952. 111 indexed citations

Chang, Ting‐Tsung, Myron J. Tong, Piyawat Komolmit, et al.. (2006). Durability of HBeAg seroconversion following adefovir dipivoxil treatment for chronic hepatitis B. Journal of Hepatology. 44. 7 indexed citations

Huang, Yi‐Hsiang, Chien‐Hung Chen, Ting‐Tsung Chang, et al.. (2005). Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery. Journal of Gastroenterology and Hepatology. 20(5). 765–771. 48 indexed citations

Cheng, Pin‐Nan, Patrick Marcellin, Bruce R. Bacon, et al.. (2004). Racial differences in responses to interferon‐β‐1a in chronic hepatitis C unresponsive to interferon‐α: a better response in Chinese patients. Journal of Viral Hepatitis. 11(5). 418–426. 17 indexed citations

Chang, Ting‐Tsung, et al.. (2004). Four years of lamivudine treatment in Chinese patients with chronic hepatitis B. Journal of Gastroenterology and Hepatology. 19(11). 1276–1282. 207 indexed citations

10.

Chang, Ting‐Tsung, S. Hadziyannis, J Cianciara, et al.. (2002). Sustained viral load and ALT reduction following 48 weeks of entecavir treatment in subjects with chronic hepatitis B who have failed lamivudine.. Hepatology. 36(4). 21 indexed citations

11.

Marcellin, Patrick, Ting‐Tsung Chang, Seng Gee Lim, et al.. (2002). 48 weeks of adefovir dipivoxil (ADV) results in improvement in fibrosis and decreased progression of fibrosis in a double-blind, randomized, placebo-controlled study for the treatment of patients with HBeAg plus chronic hepatitis B.. Hepatology. 36(4). 3 indexed citations

12.

Young, Kung-Chia, et al.. (2002). A reverse-transcription competitive PCR assay based on chemiluminescence hybridization for detection and quantification of hepatitis C virus RNA. Journal of Virological Methods. 103(1). 27–39. 17 indexed citations

13.

Yao, Wei‐Jen, Shan‐Tair Wang, Nan‐Haw Chow, et al.. (2002). Serum tissue polypeptide specific antigen as a noninvasive prognostic indicator for early recurrence of hepatocellular carcinoma after curative resection. Cancer. 95(1). 112–118. 5 indexed citations

14.

Lin, Chung‐Chih, J.‐C. Wu, Ting‐Tsung Chang, et al.. (2001). Long‐term evaluation of recombinant interferon α2b in the treatment of patients with hepatitis B e antigen‐negative chronic hepatitis B in Taiwan. Journal of Viral Hepatitis. 8(6). 438–446. 16 indexed citations

15.

Marcellin, Patrick, Ting‐Tsung Chang, Seng Gee Lim, et al.. (2001). GS-98-437 a double-blind, randomized, placebo-controlled study of adefovir dipivoxil (ADV) for the treatment of patients with HBeAg+ chronic hepatitis B infection: 48 week results.. Hepatology. 34(4). 13 indexed citations

16.

Liaw, Yun‐Fan, Nancy W.Y. Leung, Ting‐Tsung Chang, et al.. (2000). Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Gastroenterology. 119(1). 172–180. 575 indexed citations breakdown →

17.

Chang, Ting‐Tsung, et al.. (1998). Differences in Risk Factors for Being Either a Hepatitis B Carrier or Anti-Hepatitis C+ in a Hepatoma-Hyperendemic Area in Rural Taiwan. Journal of Clinical Epidemiology. 51(9). 733–738. 38 indexed citations

18.

Chang, Ting‐Tsung, Ching‐Yih Lin, Jeng‐Shiann Shin, et al.. (1995). Endoscopic variceal ligation versus conservative treatment for patients with hepatocellular carcinoma and bleeding esophageal varices. Gastrointestinal Endoscopy. 42(6). 535–539. 9 indexed citations

19.

Chao, Yee, Fa‐Yauh Lee, Yang‐Te Tsai, et al.. (1989). Muscle cramps in liver cirrhosis. Weichangbingxue. 6(3). 163–169. 6 indexed citations

20.

Lee, Fa‐Yauh, et al.. (1989). Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg-positive cirrhosis. Hepatology. 10(3). 283–287. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact